Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer’s disease ; volume:7 ; number:1 ; day:24 ; month:7 ; year:2015 ; pages:1-12 ; date:12.2015
Alzheimer's research & therapy ; 7, Heft 1 (24.7.2015), 1-12, 12.2015
- Urheber
-
Rijpma, Anne
Meulenbroek, Olga
van Hees, Anneke M. J.
Sijben, John W. C.
Vellas, Bruno
Shah, Raj C.
Bennett, David A.
Scheltens, Philip
Olde Rikkert, Marcel G. M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-015-0134-1
- URN
-
urn:nbn:de:101:1-2019112104032394110959
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rijpma, Anne
- Meulenbroek, Olga
- van Hees, Anneke M. J.
- Sijben, John W. C.
- Vellas, Bruno
- Shah, Raj C.
- Bennett, David A.
- Scheltens, Philip
- Olde Rikkert, Marcel G. M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Plaque complement activation and cognitive loss in Alzheimer's disease
Single-nucleus RNA velocity reveals critical synaptic and cell-cycle dysregulations in neuropathologically confirmed Alzheimer’s disease
Genome-wide epistasis analysis for Alzheimer’s disease and implications for genetic risk prediction
Protein farnesylation is upregulated in Alzheimer’s human brains and neuron-specific suppression of farnesyltransferase mitigates pathogenic processes in Alzheimer’s model mice
Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer’s disease subjects: an exploratory study
Estimating attrition in mild-to-moderate Alzheimer’s disease and mild cognitive impairment clinical trials
Epistatic effects of IGHG and FCGRIIB genes on the development of Alzheimer’s disease in African Americans
TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer’s disease
Mitigation of synaptic and memory impairments via F-actin stabilization in Alzheimer’s disease
Dysphagia is closely related to frailty in mild-to-moderate Alzheimer’s disease
Effects of brain microRNAs in cognitive trajectory and Alzheimer’s disease
Pathologic and clinical correlates of region-specific brain GFAP in Alzheimer’s disease
Plaque complement activation and cognitive loss in Alzheimer's disease
Single-nucleus RNA velocity reveals critical synaptic and cell-cycle dysregulations in neuropathologically confirmed Alzheimer’s disease
Genome-wide epistasis analysis for Alzheimer’s disease and implications for genetic risk prediction
Protein farnesylation is upregulated in Alzheimer’s human brains and neuron-specific suppression of farnesyltransferase mitigates pathogenic processes in Alzheimer’s model mice
Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer’s disease subjects: an exploratory study
Estimating attrition in mild-to-moderate Alzheimer’s disease and mild cognitive impairment clinical trials
Epistatic effects of IGHG and FCGRIIB genes on the development of Alzheimer’s disease in African Americans
TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer’s disease
Mitigation of synaptic and memory impairments via F-actin stabilization in Alzheimer’s disease
Dysphagia is closely related to frailty in mild-to-moderate Alzheimer’s disease
Effects of brain microRNAs in cognitive trajectory and Alzheimer’s disease
Pathologic and clinical correlates of region-specific brain GFAP in Alzheimer’s disease
Plaque complement activation and cognitive loss in Alzheimer's disease
Single-nucleus RNA velocity reveals critical synaptic and cell-cycle dysregulations in neuropathologically confirmed Alzheimer’s disease
Genome-wide epistasis analysis for Alzheimer’s disease and implications for genetic risk prediction
Protein farnesylation is upregulated in Alzheimer’s human brains and neuron-specific suppression of farnesyltransferase mitigates pathogenic processes in Alzheimer’s model mice
Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer’s disease subjects: an exploratory study
Estimating attrition in mild-to-moderate Alzheimer’s disease and mild cognitive impairment clinical trials
Epistatic effects of IGHG and FCGRIIB genes on the development of Alzheimer’s disease in African Americans
TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer’s disease
Mitigation of synaptic and memory impairments via F-actin stabilization in Alzheimer’s disease
Dysphagia is closely related to frailty in mild-to-moderate Alzheimer’s disease
Effects of brain microRNAs in cognitive trajectory and Alzheimer’s disease